Literature DB >> 6487464

Stereoselective binding of propranolol enantiomers to human alpha 1-acid glycoprotein and human plasma.

F Albani, R Riva, M Contin, A Baruzzi.   

Abstract

The binding of propranolol enantiomers to human albumin (ALB), alpha 1-acid glycoprotein (alpha 1-AGP) and plasma was studied. (-) propranolol is more bound than (+)propranolol to alpha 1-AGP (P less than 0.001) and to plasma (P less than 0.05). In solutions containing ALB at a constant concentration (580 mumol/l) and alpha 1-AGP at increasing concentrations, the binding of both isomers increases but the stereo selectivity is evident throughout the alpha 1-AGP concentration range examined (25-100 mumol/l).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6487464      PMCID: PMC1463537          DOI: 10.1111/j.1365-2125.1984.tb02462.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  14 in total

1.  The binding of catecholamines to human serum proteins.

Authors:  G Powis
Journal:  Biochem Pharmacol       Date:  1975-03-15       Impact factor: 5.858

2.  High stereospecificity of the benzodiazepine binding site on human serum albumin. Studies with d- and l-oxazepam hemisuccinate.

Authors:  W E Müller; U Wollert
Journal:  Mol Pharmacol       Date:  1975-01       Impact factor: 4.436

3.  The anticonvulsant action of the (-)- and (+)-enantiomers of propranolol.

Authors:  G Anlezark; R Horton; B Meldrum
Journal:  J Pharm Pharmacol       Date:  1979-07       Impact factor: 3.765

4.  Pharmacokinetics of dextro-, laevo- and racemic propranolol in man.

Authors:  C F George; T Fenyvesi; M E Conolly; C T Dollery
Journal:  Eur J Clin Pharmacol       Date:  1972-03       Impact factor: 2.953

5.  Simple and rapid determination of propranolol and its active metabolite, 4-hydroxypropranolol, in human plasma by liquid chromatography with fluorescence detection.

Authors:  F Albani; R Riva; A Baruzzi
Journal:  J Chromatogr       Date:  1982-03-12

6.  Short-term clinical trial of phopranolol in racemic form (Inderal), D-propranolol and placebo in migraine.

Authors:  P Stensrud; O Sjaastad
Journal:  Acta Neurol Scand       Date:  1976-03       Impact factor: 3.209

7.  Pharmacokinetics of propranolol isomers and their relationships with beta adrenoceptor blocking activity in rabbits administered with dl-propranolol.

Authors:  K Kawashima; H Ishikawa
Journal:  J Pharmacol Exp Ther       Date:  1980-06       Impact factor: 4.030

8.  No stereoselective first-pass hepatic extraction of propranolol.

Authors:  G P Jackman; A J McLean; G L Jennings; A Bobik
Journal:  Clin Pharmacol Ther       Date:  1981-09       Impact factor: 6.875

9.  Cardiac electrophysiologic properties of dl-propranolol, d-propranolol, l-propranolol and dl-pindolol in anesthetized dogs.

Authors:  P Jaillon; J Hecklé; J Weissenburger; G Cheymol
Journal:  J Pharmacol Exp Ther       Date:  1980-02       Impact factor: 4.030

10.  Pharmacokinetics and pharmacodynamics of propranolol stereoisomers in hyperthyroid patients.

Authors:  K Tawara; K Kawashima; H Ishikawa; K Yamamoto; K Saito; A Ebihara; S Yoshida
Journal:  Eur J Clin Pharmacol       Date:  1981-02       Impact factor: 2.953

View more
  10 in total

Review 1.  Methods of determining plasma and tissue binding of drugs. Pharmacokinetic consequences.

Authors:  G M Pacifici; A Viani
Journal:  Clin Pharmacokinet       Date:  1992-12       Impact factor: 6.447

2.  Stereoselective binding of propranolol in the elderly.

Authors:  P Colangelo; M Chandler; R Blouin; P McNamara
Journal:  Br J Clin Pharmacol       Date:  1989-04       Impact factor: 4.335

Review 3.  Importance of drug enantiomers in clinical pharmacology.

Authors:  K Williams; E Lee
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

4.  Evidence for differences in the binding of drugs to the two main genetic variants of human alpha 1-acid glycoprotein.

Authors:  F Herve; E Gomas; J C Duche; J P Tillement
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

5.  Enantioselective disposition of ofloxacin in humans.

Authors:  O Okazaki; C Kojima; H Hakusui; M Nakashima
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

6.  Selective effect of adjuvant arthritis on the disposition of propranolol enantiomers in rats detected using a stereospecific HPLC assay.

Authors:  M Piquette-Miller; F Jamali
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

7.  On-column entrapment of alpha1-acid glycoprotein for studies of drug-protein binding by high-performance affinity chromatography.

Authors:  Jeanethe Anguizola; Cong Bi; Michelle Koke; Abby Jackson; David S Hage
Journal:  Anal Bioanal Chem       Date:  2016-06-11       Impact factor: 4.142

8.  Stereoselective binding of tertatolol and of 4-hydroxytertatolol to human plasma proteins.

Authors:  G Bastian; S Urien; F Brée; P Jolliet; I Rocher; O Crambes; J P Tillement
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1992 Jul-Sep       Impact factor: 2.441

9.  The pharmacokinetics of d-sotalol and d,l-sotalol in healthy volunteers.

Authors:  J M Poirier; P Jaillon; B Lecocq; V Lecocq; A Ferry; G Cheymol
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

10.  Population Pharmacokinetics and Pharmacodynamics of Oral Propranolol in Pediatric Patients With Infantile Hemangioma.

Authors:  Tomoki Takechi; Tadao Kumokawa; Rumiko Kato; Takeshi Higuchi; Tsuyoshi Kaneko; Ichiro Ieiri
Journal:  J Clin Pharmacol       Date:  2018-05-10       Impact factor: 3.126

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.